Multivitamin use after diagnosis and prostate cancer survival among men with nonmetastatic prostate cancer.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
29
07
2023
accepted:
04
03
2024
revised:
29
02
2024
medline:
16
3
2024
pubmed:
16
3
2024
entrez:
16
3
2024
Statut:
aheadofprint
Résumé
Multivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer survival is largely unknown, and some evidence even suggests potential harm. We prospectively assessed post-diagnostic multivitamin use in relation to prostate cancer survival among 4756 men with nonmetastatic prostate cancer at diagnosis in the Health Professionals Follow-up Study (1986-2016). Cox regression models were used to evaluate the association between post-diagnostic multivitamin use and frequency and risk of lethal prostate cancer (distant metastases or prostate cancer-specific death) and all-cause mortality. We observed 438 lethal prostate cancer and 2609 deaths during a median follow-up of 11 years. Compared to non-users, post-diagnostic multivitamin use was not associated with risk of lethal prostate cancer (HR [95% CI], 0.98 [0.74-1.30]) or all-cause mortality (1.00 [0.88-1.12]), after adjustment for potential confounders. Similarly, null associations were observed across various categories of use frequency. Compared to non-users, men who used multivitamins regularly (6-9 tablets/week) after cancer diagnosis had similar risk of lethal prostate cancer (0.96 [0.72-1.28]) and all-cause mortality (0.99 [0.88-1.12]). We found no evidence that post-diagnostic multivitamin use among men with nonmetastatic prostate cancer was associated with better or worse survival in a well-nourished population.
Sections du résumé
BACKGROUND
BACKGROUND
Multivitamin use is common among cancer patients. Whether post-diagnostic multivitamin supplementation is beneficial for prostate cancer survival is largely unknown, and some evidence even suggests potential harm.
METHODS
METHODS
We prospectively assessed post-diagnostic multivitamin use in relation to prostate cancer survival among 4756 men with nonmetastatic prostate cancer at diagnosis in the Health Professionals Follow-up Study (1986-2016). Cox regression models were used to evaluate the association between post-diagnostic multivitamin use and frequency and risk of lethal prostate cancer (distant metastases or prostate cancer-specific death) and all-cause mortality.
RESULTS
RESULTS
We observed 438 lethal prostate cancer and 2609 deaths during a median follow-up of 11 years. Compared to non-users, post-diagnostic multivitamin use was not associated with risk of lethal prostate cancer (HR [95% CI], 0.98 [0.74-1.30]) or all-cause mortality (1.00 [0.88-1.12]), after adjustment for potential confounders. Similarly, null associations were observed across various categories of use frequency. Compared to non-users, men who used multivitamins regularly (6-9 tablets/week) after cancer diagnosis had similar risk of lethal prostate cancer (0.96 [0.72-1.28]) and all-cause mortality (0.99 [0.88-1.12]).
CONCLUSIONS
CONCLUSIONS
We found no evidence that post-diagnostic multivitamin use among men with nonmetastatic prostate cancer was associated with better or worse survival in a well-nourished population.
Identifiants
pubmed: 38491175
doi: 10.1038/s41416-024-02651-5
pii: 10.1038/s41416-024-02651-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999-2012. Jama. 2016;316:1464–74.
doi: 10.1001/jama.2016.14403
pubmed: 27727382
pmcid: 5540241
Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. J Nutr. 2011;141:261–6. https://doi.org/10.3945/jn.110.133025 .
doi: 10.3945/jn.110.133025.
pubmed: 21178089
Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26:665–73. https://doi.org/10.1200/JCO.2007.13.5905 .
doi: 10.1200/JCO.2007.13.5905.
pubmed: 18235127
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:243–74. https://doi.org/10.3322/caac.21142 .
doi: 10.3322/caac.21142.
pubmed: 22539238
National Cancer Institute SEER Program. Cancer Stat Facts: Prostate Cancer. Accessed 24 Jan 2022, https://seer.cancer.gov/statfacts/html/prost.html .
Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology. 2005;66:1223–8. https://doi.org/10.1016/j.urology.2005.06.003 .
doi: 10.1016/j.urology.2005.06.003.
pubmed: 16360447
Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002;168:2505–9. https://doi.org/10.1097/01.ju.0000037733.62447.50 .
doi: 10.1097/01.ju.0000037733.62447.50.
pubmed: 12441950
Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther PJ, Robertson CN, et al. Supplement use among men with prostate cancer. Urology. 2005;66:161–6. https://doi.org/10.1016/j.urology.2005.01.035 .
doi: 10.1016/j.urology.2005.01.035.
pubmed: 15992901
Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, et al. Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer. J Urol. 2019;202:689–95. https://doi.org/10.1097/JU.0000000000000336 .
doi: 10.1097/JU.0000000000000336.
pubmed: 31091175
pmcid: 7017721
Van Blarigan E, Kenfield SA, Cedars BE, Broering J, Cowan JE, Carroll P, et al. Multivitamin use and risk of prostate cancer recurrence: Data from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Am Soc Clin Oncol. 2018. https://doi.org/10.1200/JCO.2018.36.6_suppl.70 .
Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, et al. Multivitamins in the prevention of cancer in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2012;308:1871–80. https://doi.org/10.1001/jama.2012.14641 .
doi: 10.1001/jama.2012.14641.
pubmed: 23162860
pmcid: 3517179
Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol. 2011;173:906–14. https://doi.org/10.1093/aje/kwq447 .
doi: 10.1093/aje/kwq447.
pubmed: 21343248
pmcid: 3105257
Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control. 2009;20:691–8. https://doi.org/10.1007/s10552-008-9282-y .
doi: 10.1007/s10552-008-9282-y.
pubmed: 19093214
Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomark Prev. 1999;8:887–92.
Zhang Y, Song M, Mucci LA, Giovannucci EL. Regular, long-duration multivitamin use and risk of overall and aggressive prostate cancer in the health professionals follow-up study. J Urol. 2022;208:633–40. https://doi.org/10.1097/JU.0000000000002735 .
doi: 10.1097/JU.0000000000002735.
pubmed: 35522215
pmcid: 9378679
Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754–64. https://doi.org/10.1093/jnci/djk177 .
doi: 10.1093/jnci/djk177.
pubmed: 17505071
Stevens VL, McCullough ML, Diver WR, Rodriguez C, Jacobs EJ, Thun MJ, et al. Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control. 2005;16:643–50. https://doi.org/10.1007/s10552-005-0384-5 .
doi: 10.1007/s10552-005-0384-5.
pubmed: 16049802
Watkins ML, Erickson JD, Thun MJ, Mulinare J, Heath CW Jr. Multivitamin use and mortality in a large prospective study. Am J Epidemiol. 2000;152:149–62. https://doi.org/10.1093/aje/152.2.149 .
doi: 10.1093/aje/152.2.149.
pubmed: 10909952
Kim HJ, Giovannucci E, Rosner B, Willett WC, Cho E. Longitudinal and secular trends in dietary supplement use: nurses’ health study and health professionals follow-up study, 1986-2006. J Acad Nutr Dietetics. 2014;114:436–43.
doi: 10.1016/j.jand.2013.07.039
Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114–26. https://doi.org/10.1093/oxfordjournals.aje.a116211 .
doi: 10.1093/oxfordjournals.aje.a116211
pubmed: 1632423
Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140:1016–9. https://doi.org/10.1093/oxfordjournals.aje.a117191 .
doi: 10.1093/oxfordjournals.aje.a117191
pubmed: 7985649
Cain KC, Harlow SD, Little RJ, Nan B, Yosef M, Taffe JR, et al. Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes. Am J Epidemiol. 2011;173:1078–84. https://doi.org/10.1093/aje/kwq481 .
doi: 10.1093/aje/kwq481.
pubmed: 21422059
pmcid: 3121224
Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121:1571–8. https://doi.org/10.1002/ijc.22788 .
doi: 10.1002/ijc.22788.
pubmed: 17450530
pmcid: 2430098
Zhang Y, Stopsack KH, Wu K, Song M, Mucci LA, Giovannucci E Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer. J Urol. 2022:101097JU0000000000003080. https://doi.org/10.1097/JU.0000000000003080 .
Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, L Giovannucci E, Chan JM. Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst. 2015;107:360 https://doi.org/10.1093/jnci/dju360 .
doi: 10.1093/jnci/dju360.
pubmed: 25505227
Ladas EJ, Jacobson JS, Kennedy DD, Teel K, Fleischauer A, Kelly KM. Antioxidants and cancer therapy: a systematic review. J Clin Oncol. 2004;22:517–28. https://doi.org/10.1200/JCO.2004.03.086 .
doi: 10.1200/JCO.2004.03.086.
pubmed: 14752075
Margalit DN, Kasperzyk JL, Martin NE, Sesso HD, Gaziano JM, Ma J, et al. Beta-carotene antioxidant use during radiation therapy and prostate cancer outcome in the Physicians’ Health Study. Int J Radiat Oncol Biol Phys. 2012;83:28–32. https://doi.org/10.1016/j.ijrobp.2011.05.032 .
doi: 10.1016/j.ijrobp.2011.05.032.
pubmed: 22079732
Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173:355–61. https://doi.org/10.1001/jamainternmed.2013.2299 .
doi: 10.1001/jamainternmed.2013.2299.
pubmed: 23381623
Macpherson H, Pipingas A, Pase MP. Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2013;97:437–44. https://doi.org/10.3945/ajcn.112.049304 .
doi: 10.3945/ajcn.112.049304.
pubmed: 23255568
Davies AA, Davey Smith G, Harbord R, Bekkering GE, Sterne JA, Beynon R, et al. Nutritional interventions and outcome in patients with cancer or preinvasive lesions: systematic review. J Natl Cancer Inst. 2006;98:961–73. https://doi.org/10.1093/jnci/djj263 .
doi: 10.1093/jnci/djj263.
pubmed: 16849679
Saquib J, Rock CL, Natarajan L, Saquib N, Newman VA, Patterson RE, et al. Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer. Nutr Cancer. 2011;63:327–33. https://doi.org/10.1080/01635581.2011.535957 .
doi: 10.1080/01635581.2011.535957.
pubmed: 21391124
pmcid: 3078826
Kwan ML, Greenlee H, Lee VS, Castillo A, Gunderson EP, Habel LA, et al. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the life after cancer epidemiology study. Breast Cancer Res Treat. 2011;130:195–205. https://doi.org/10.1007/s10549-011-1557-4 .
doi: 10.1007/s10549-011-1557-4.
pubmed: 21559824
pmcid: 3272363
Ng K, Meyerhardt JA, Chan JA, Niedzwiecki D, Hollis DR, Saltz LB, et al. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2010;28:4354–63. https://doi.org/10.1200/JCO.2010.28.0362 .
doi: 10.1200/JCO.2010.28.0362.
pubmed: 20805450
pmcid: 2954134
Zuniga KB, Chan JM, Ryan CJ, Kenfield SA. Diet and lifestyle considerations for patients with prostate cancer. Urol Oncol. 2020;38:105–17. https://doi.org/10.1016/j.urolonc.2019.06.018 .
doi: 10.1016/j.urolonc.2019.06.018.
pubmed: 31327752
Wang P, Giovannucci EL. Are exposure-disease relationships assessed in cohorts of health professionals generalizable?: a comparative analysis based on WCRF/AICR systematic literature reviews. Cancer Causes Control. 2022; https://doi.org/10.1007/s10552-022-01633-3 .